ASP Isotopes (NASDAQ:ASPI) Shares Up 10.3% - Here's Why

Key Points

• ASP Isotopes shares jumped 10.3% to $5.63 on Friday, with mid‑day volume of about 1.35 million shares — roughly 74% below its average session volume.
• The company reported a major earnings miss, posting EPS of ($0.84) versus consensus (‑$0.14) and reported deeply negative net margins and return on equity, signaling significant unprofitability.
• Analyst coverage is mixed (two Buys, one Sell; MarketBeat average rating: "Hold" with an average price target of $13), while insiders own 14.4% and institutions about 16.8% of the stock, with the COO selling 25,000 shares in March.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s share price shot up 10.3% during trading on Friday . The company traded as high as $5.63 and last traded at $5.6340. 1,350,372 shares were traded during mid-day trading, a decline of 74% from the average session volume of 5,224,923 shares. The stock had previously closed at $5.11.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ASPI. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of ASP Isotopes in a research note on Friday, March 27th. Canaccord Genuity Group reaffirmed a "buy" rating and issued a $11.00 price objective on shares of ASP Isotopes in a research note on Tuesday. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $13.00.

ASP Isotopes Stock Performance

The stock has a 50 day moving average of $5.07 and a 200 day moving average of $6.77. The company has a quick ratio of 6.10, a current ratio of 6.14 and a debt-to-equity ratio of 1.04. The company has a market capitalization of $676.08 million, a price-to-earnings ratio of -2.51 and a beta of 3.59.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its earnings results on Friday, April 10th. The company reported ($0.84) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.70). The business had revenue of $33.32 million during the quarter, compared to the consensus estimate of $2.03 million. ASP Isotopes had a negative return on equity of 307.82% and a negative net margin of 734.14%. As a group, analysts predict that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insiders Place Their Bets

In other ASP Isotopes news, COO Robert Ainscow sold 25,000 shares of ASP Isotopes stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $4.51, for a total value of $112,750.00. Following the completion of the sale, the chief operating officer directly owned 1,512,817 shares in the company, valued at approximately $6,822,804.67. The trade was a 1.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 14.40% of the company's stock.

Institutional Investors Weigh In On ASP Isotopes

Hedge funds have recently added to or reduced their stakes in the business. Rovida Investment Management Ltd increased its holdings in ASP Isotopes by 45.5% in the third quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company's stock worth $30,688,000 after purchasing an additional 1,000,000 shares in the last quarter. Caprock Group LLC bought a new stake in ASP Isotopes in the third quarter worth approximately $2,747,000. Sara Bay Financial bought a new stake in ASP Isotopes in the third quarter worth approximately $8,688,000. SPX Gestao de Recursos Ltda bought a new stake in ASP Isotopes in the third quarter worth approximately $1,054,000. Finally, Rathbones Group PLC increased its holdings in ASP Isotopes by 68.6% in the fourth quarter. Rathbones Group PLC now owns 399,599 shares of the company's stock worth $2,138,000 after purchasing an additional 162,535 shares in the last quarter. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.